Mylan NV will sell a generic version of its EpiPen at half the price of the branded $600 emergency allergy shots in coming weeks, bowing to pressure from U.S. lawmakers who last week derided earlier steps as a mere public-relations fix.

Source: Mylan Plans Generic EpiPen to Quell Outcry Over $600 Cost – Bloomberg